LUMOS DIAGNOSTICS HOLDINGS LIMITED - Announcements

17.9%

16.5¢

Market Cap $127.9M

Healthcare Medical Instruments & Supplies

Lumos Diagnostics Holdings Limited is an Australia-based company specializes in... Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. It manages the full development program for POC assays.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

LDX	Section 708A Cleansing Statement		11/09/25	219.92KB	Share
LDX	Application for quotation of securities - LDX		11/09/25	17.58KB	Share
LDX	Lumos Signs Second ANZ FebriDx Distribution Agreement		09/09/25	222.9KB	Share
LDX	Lumos Completes A$5.0 million Loan Facility		09/09/25	192.64KB	Share
LDX	Notification regarding unquoted securities - LDX		08/09/25	17.18KB	Share
LDX	Section 708A Cleansing Statement		04/09/25	217.79KB	Share
LDX	Application for quotation of securities - LDX		04/09/25	23.11KB	Share
LDX	FY25 Results Investor Briefing Presentation		02/09/25	3.35MB	Share
LDX	Section 708A Cleansing Statement		02/09/25	216.52KB	Share
LDX	Application for quotation of securities - LDX		02/09/25	17.42KB	Share
LDX	Lumos secures follow-on PKU contract with Aptatek	PRICE SENSITIVE	01/09/25	297.04KB	Share
LDX	LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study	PRICE SENSITIVE	01/09/25	301.66KB	Share
LDX	Appendix 4G and Corporate Governance		28/08/25	702.62KB	Share
LDX	FY25 Annual Report		28/08/25	6.69MB	Share
LDX	FY25 Appendix 4E	PRICE SENSITIVE	28/08/25	108.34KB	Share
LDX	Section 708A Cleansing Statement and Excluded Information		26/08/25	188.58KB	Share
LDX	Application for quotation of securities - LDX		26/08/25	17.42KB	Share
LDX	FY25 Results - Investor Briefing Invitation		26/08/25	172.5KB	Share
LDX	Lumos Announces FebriDx CLIA Waiver Application Submission	PRICE SENSITIVE	18/08/25	199.18KB	Share
LDX	Lumos Partners with PRO-spectus for FebriDx Market Access		14/08/25	204.15KB	Share
LDX	Waiver of ASX Listing Rule 10.1 Granted		13/08/25	236.59KB	Share
LDX	Q4 FY25 Results Investor Briefing		21/07/25	3.23MB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	21/07/25	521.46KB	Share
LDX	Proposed issue of securities - LDX		17/07/25	17.21KB	Share
LDX	Lumos Signs Binding Term Sheet for A$5M Loan Facility	PRICE SENSITIVE	17/07/25	265.34KB	Share
LDX	Investor Briefing Presentation		16/07/25	1.77MB	Share
LDX	Investor Briefing Invitation		16/07/25	217.01KB	Share
LDX	Reinstatement to Quotation	PRICE SENSITIVE	16/07/25	116.19KB	Share
LDX	Lumos Signs Pivotal US FebriDx Agreement	PRICE SENSITIVE	16/07/25	274.53KB	Share
LDX	Suspension from Quotation	PRICE SENSITIVE	15/07/25	252.07KB	Share
LDX	Trading Halt	PRICE SENSITIVE	11/07/25	261.28KB	Share
LDX	Pause in Trading	PRICE SENSITIVE	11/07/25	113.46KB	Share
LDX	Notification of cessation of securities - LDX		02/07/25	15.89KB	Share
LDX	Lumos Receives Research & Development Tax Rebate		23/06/25	224.12KB	Share
LDX	Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone	PRICE SENSITIVE	18/06/25	253.79KB	Share
LDX	FebriDx to Support Antimicrobial Stewardship in GP Trial		17/06/25	261.82KB	Share
LDX	Change of Registered Office and Principal Place of Business		02/06/25	207.1KB	Share
LDX	Lumos Reaches Recruitment Milestone in FebriDx Study	PRICE SENSITIVE	02/06/25	253.61KB	Share
LDX	Lumos Secures Sixth US Medicare Reimbursement for FebriDx	PRICE SENSITIVE	27/05/25	308.44KB	Share
LDX	Lumos Secures Fifth US Medicare Reimbursement for FebriDx	PRICE SENSITIVE	19/05/25	309.53KB	Share
LDX	Lumos Advances FebriDx Sales with iMedical Purchase Order	PRICE SENSITIVE	14/05/25	221.67KB	Share
LDX	Notification regarding unquoted securities - LDX		09/05/25	18.24KB	Share
LDX	Q3 FY25 Investor Briefing		06/05/25	3MB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/25	355.68KB	Share
LDX	Lumos Secures Further US Medicare Reimbursement for FebriDx	PRICE SENSITIVE	23/04/25	418.31KB	Share
LDX	Lumos Secures Key US Reimbursement Milestones for FebriDx	PRICE SENSITIVE	17/04/25	398.63KB	Share
LDX	Notification of cessation of securities - LDX		14/04/25	16.02KB	Share
LDX	Investor Presentation		02/04/25	6.78MB	Share
LDX	Investor Information Session Invitation		24/03/25	207.01KB	Share
LDX	1H FY25 Results Investor Briefing		03/03/25	538.33KB	Share
LDX	Hologic Development Agreement Expanded Scope of Works	PRICE SENSITIVE	03/03/25	250.29KB	Share
LDX	Appendix 4D and Half Year Report	PRICE SENSITIVE	27/02/25	672.2KB	Share
LDX	1H FY25 Results Investor Briefing Invitation		25/02/25	207.9KB	Share
LDX	Q2 FY25 Results Investor Briefing Invitation		05/02/25	1.14MB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	428.29KB	Share
LDX	Notification of cessation of securities - LDX		13/01/25	14.47KB	Share
LDX	Lumos Partners with MedPro for Sales of FebriDx in the US		13/01/25	296.82KB	Share
LDX	Notification of cessation of securities - LDX		09/01/25	13.99KB	Share
LDX	Listing Rule 6.22.2 Adjustment to Option Exercise Prices		20/12/24	222.95KB	Share
LDX	Application for quotation of securities - LDX		20/12/24	17.69KB	Share
LDX	Section 708A Cleansing Statement		20/12/24	189.22KB	Share
LDX	Commencement of FebriDx CLIA Waiver Study	PRICE SENSITIVE	19/12/24	341.9KB	Share
LDX	Notification regarding unquoted securities - LDX		13/12/24	19.02KB	Share
LDX	Change of Director's Interest Notice - DW		10/12/24	306.64KB	Share
LDX	Application for quotation of securities - LDX		06/12/24	17.52KB	Share
LDX	Section 708A Cleansing Statement		06/12/24	218.39KB	Share
LDX	Lumos receives CPT PLA Code for FebriDX in the US	PRICE SENSITIVE	05/12/24	255.17KB	Share
LDX	Results of Annual General Meeting		14/11/24	155.99KB	Share
LDX	2024 AGM Presentation		14/11/24	3.33MB	Share
LDX	AGM Chair Address		14/11/24	333.6KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/24	525.45KB	Share
LDX	Lumos and BARDA Partnership - Investor Briefing Recording		16/10/24	171.11KB	Share
LDX	Cancel - Proposed issue of securities - LDX		14/10/24	16.93KB	Share
LDX	Proposed issue of securities - LDX		14/10/24	15.53KB	Share
LDX	Notice of Annual General Meeting and Proxy Form		14/10/24	616.2KB	Share
LDX	Change in substantial holding		11/10/24	144.65KB	Share
LDX	Lumos and BARDA Partnership - Investor Presentation		11/10/24	651.98KB	Share
LDX	Change of Director's Interest Notice - SL		10/10/24	270.05KB	Share
LDX	Change of Director's Interest Notice - CR		10/10/24	218.46KB	Share
LDX	Change of Director's Interest Notice - BLG		10/10/24	219.89KB	Share
LDX	Change in substantial holding from RYD		09/10/24	146.41KB	Share
LDX	Lumos and BARDA Partnership - Investor Briefing		09/10/24	208.69KB	Share
LDX	Notification regarding unquoted securities - LDX		09/10/24	19.8KB	Share
LDX	Application for quotation of securities - LDX		09/10/24	17.36KB	Share
LDX	Lumos Successfully Completes Retail Entitlement Offer	PRICE SENSITIVE	08/10/24	202.82KB	Share
LDX	Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study	PRICE SENSITIVE	03/10/24	287.36KB	Share
LDX	Lumos Awarded National Contract with MediGroup for FebriDx	PRICE SENSITIVE	25/09/24	264.86KB	Share
LDX	Ceasing to be a substantial holder		23/09/24	44.12KB	Share
LDX	Change in substantial holding from RYD		23/09/24	143.67KB	Share
LDX	Investor Roadshow Presentation		23/09/24	13.89MB	Share
LDX	Lumos Achieves First Phase 2 Milestone in Hologic Agreement	PRICE SENSITIVE	20/09/24	231.79KB	Share
LDX	Change in substantial holding		19/09/24	133.39KB	Share
LDX	Change in substantial holder		16/09/24	162.94KB	Share
LDX	Change in substantial holding		16/09/24	126.59KB	Share
LDX	Lumos Appoints Thermo Fisher Scientific as US Distributor	PRICE SENSITIVE	16/09/24	171.99KB	Share
LDX	Change in substantial holding from RYD		13/09/24	146.68KB	Share
LDX	Application for quotation of securities - LDX		12/09/24	17.31KB	Share
LDX	Letter to Ineligible Shareholders		11/09/24	130.82KB	Share
LDX	Letter to Eligible Shareholders		11/09/24	18.22MB	Share
LDX	Retail Entitlement Offer Booklet	PRICE SENSITIVE	11/09/24	17.57MB	Share

LDX Section 708A Cleansing Statement
11/09/25		219.92KB	Share
LDX Application for quotation of securities - LDX
11/09/25		17.58KB	Share
LDX Lumos Signs Second ANZ FebriDx Distribution Agreement
09/09/25		222.9KB	Share
LDX Lumos Completes A$5.0 million Loan Facility
09/09/25		192.64KB	Share
LDX Notification regarding unquoted securities - LDX
08/09/25		17.18KB	Share
LDX Section 708A Cleansing Statement
04/09/25		217.79KB	Share
LDX Application for quotation of securities - LDX
04/09/25		23.11KB	Share
LDX FY25 Results Investor Briefing Presentation
02/09/25		3.35MB	Share
LDX Section 708A Cleansing Statement
02/09/25		216.52KB	Share
LDX Application for quotation of securities - LDX
02/09/25		17.42KB	Share
LDX Lumos secures follow-on PKU contract with Aptatek
01/09/25	PRICE SENSITIVE	297.04KB	Share
LDX LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study
01/09/25	PRICE SENSITIVE	301.66KB	Share
LDX Appendix 4G and Corporate Governance
28/08/25		702.62KB	Share
LDX FY25 Annual Report
28/08/25		6.69MB	Share
LDX FY25 Appendix 4E
28/08/25	PRICE SENSITIVE	108.34KB	Share
LDX Section 708A Cleansing Statement and Excluded Information
26/08/25		188.58KB	Share
LDX Application for quotation of securities - LDX
26/08/25		17.42KB	Share
LDX FY25 Results - Investor Briefing Invitation
26/08/25		172.5KB	Share
LDX Lumos Announces FebriDx CLIA Waiver Application Submission
18/08/25	PRICE SENSITIVE	199.18KB	Share
LDX Lumos Partners with PRO-spectus for FebriDx Market Access
14/08/25		204.15KB	Share
LDX Waiver of ASX Listing Rule 10.1 Granted
13/08/25		236.59KB	Share
LDX Q4 FY25 Results Investor Briefing
21/07/25		3.23MB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
21/07/25	PRICE SENSITIVE	521.46KB	Share
LDX Proposed issue of securities - LDX
17/07/25		17.21KB	Share
LDX Lumos Signs Binding Term Sheet for A$5M Loan Facility
17/07/25	PRICE SENSITIVE	265.34KB	Share
LDX Investor Briefing Presentation
16/07/25		1.77MB	Share
LDX Investor Briefing Invitation
16/07/25		217.01KB	Share
LDX Reinstatement to Quotation
16/07/25	PRICE SENSITIVE	116.19KB	Share
LDX Lumos Signs Pivotal US FebriDx Agreement
16/07/25	PRICE SENSITIVE	274.53KB	Share
LDX Suspension from Quotation
15/07/25	PRICE SENSITIVE	252.07KB	Share
LDX Trading Halt
11/07/25	PRICE SENSITIVE	261.28KB	Share
LDX Pause in Trading
11/07/25	PRICE SENSITIVE	113.46KB	Share
LDX Notification of cessation of securities - LDX
02/07/25		15.89KB	Share
LDX Lumos Receives Research & Development Tax Rebate
23/06/25		224.12KB	Share
LDX Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone
18/06/25	PRICE SENSITIVE	253.79KB	Share
LDX FebriDx to Support Antimicrobial Stewardship in GP Trial
17/06/25		261.82KB	Share
LDX Change of Registered Office and Principal Place of Business
02/06/25		207.1KB	Share
LDX Lumos Reaches Recruitment Milestone in FebriDx Study
02/06/25	PRICE SENSITIVE	253.61KB	Share
LDX Lumos Secures Sixth US Medicare Reimbursement for FebriDx
27/05/25	PRICE SENSITIVE	308.44KB	Share
LDX Lumos Secures Fifth US Medicare Reimbursement for FebriDx
19/05/25	PRICE SENSITIVE	309.53KB	Share
LDX Lumos Advances FebriDx Sales with iMedical Purchase Order
14/05/25	PRICE SENSITIVE	221.67KB	Share
LDX Notification regarding unquoted securities - LDX
09/05/25		18.24KB	Share
LDX Q3 FY25 Investor Briefing
06/05/25		3MB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25	PRICE SENSITIVE	355.68KB	Share
LDX Lumos Secures Further US Medicare Reimbursement for FebriDx
23/04/25	PRICE SENSITIVE	418.31KB	Share
LDX Lumos Secures Key US Reimbursement Milestones for FebriDx
17/04/25	PRICE SENSITIVE	398.63KB	Share
LDX Notification of cessation of securities - LDX
14/04/25		16.02KB	Share
LDX Investor Presentation
02/04/25		6.78MB	Share
LDX Investor Information Session Invitation
24/03/25		207.01KB	Share
LDX 1H FY25 Results Investor Briefing
03/03/25		538.33KB	Share
LDX Hologic Development Agreement Expanded Scope of Works
03/03/25	PRICE SENSITIVE	250.29KB	Share
LDX Appendix 4D and Half Year Report
27/02/25	PRICE SENSITIVE	672.2KB	Share
LDX 1H FY25 Results Investor Briefing Invitation
25/02/25		207.9KB	Share
LDX Q2 FY25 Results Investor Briefing Invitation
05/02/25		1.14MB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	428.29KB	Share
LDX Notification of cessation of securities - LDX
13/01/25		14.47KB	Share
LDX Lumos Partners with MedPro for Sales of FebriDx in the US
13/01/25		296.82KB	Share
LDX Notification of cessation of securities - LDX
09/01/25		13.99KB	Share
LDX Listing Rule 6.22.2 Adjustment to Option Exercise Prices
20/12/24		222.95KB	Share
LDX Application for quotation of securities - LDX
20/12/24		17.69KB	Share
LDX Section 708A Cleansing Statement
20/12/24		189.22KB	Share
LDX Commencement of FebriDx CLIA Waiver Study
19/12/24	PRICE SENSITIVE	341.9KB	Share
LDX Notification regarding unquoted securities - LDX
13/12/24		19.02KB	Share
LDX Change of Director's Interest Notice - DW
10/12/24		306.64KB	Share
LDX Application for quotation of securities - LDX
06/12/24		17.52KB	Share
LDX Section 708A Cleansing Statement
06/12/24		218.39KB	Share
LDX Lumos receives CPT PLA Code for FebriDX in the US
05/12/24	PRICE SENSITIVE	255.17KB	Share
LDX Results of Annual General Meeting
14/11/24		155.99KB	Share
LDX 2024 AGM Presentation
14/11/24		3.33MB	Share
LDX AGM Chair Address
14/11/24		333.6KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
29/10/24	PRICE SENSITIVE	525.45KB	Share
LDX Lumos and BARDA Partnership - Investor Briefing Recording
16/10/24		171.11KB	Share
LDX Cancel - Proposed issue of securities - LDX
14/10/24		16.93KB	Share
LDX Proposed issue of securities - LDX
14/10/24		15.53KB	Share
LDX Notice of Annual General Meeting and Proxy Form
14/10/24		616.2KB	Share
LDX Change in substantial holding
11/10/24		144.65KB	Share
LDX Lumos and BARDA Partnership - Investor Presentation
11/10/24		651.98KB	Share
LDX Change of Director's Interest Notice - SL
10/10/24		270.05KB	Share
LDX Change of Director's Interest Notice - CR
10/10/24		218.46KB	Share
LDX Change of Director's Interest Notice - BLG
10/10/24		219.89KB	Share
LDX Change in substantial holding from RYD
09/10/24		146.41KB	Share
LDX Lumos and BARDA Partnership - Investor Briefing
09/10/24		208.69KB	Share
LDX Notification regarding unquoted securities - LDX
09/10/24		19.8KB	Share
LDX Application for quotation of securities - LDX
09/10/24		17.36KB	Share
LDX Lumos Successfully Completes Retail Entitlement Offer
08/10/24	PRICE SENSITIVE	202.82KB	Share
LDX Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study
03/10/24	PRICE SENSITIVE	287.36KB	Share
LDX Lumos Awarded National Contract with MediGroup for FebriDx
25/09/24	PRICE SENSITIVE	264.86KB	Share
LDX Ceasing to be a substantial holder
23/09/24		44.12KB	Share
LDX Change in substantial holding from RYD
23/09/24		143.67KB	Share
LDX Investor Roadshow Presentation
23/09/24		13.89MB	Share
LDX Lumos Achieves First Phase 2 Milestone in Hologic Agreement
20/09/24	PRICE SENSITIVE	231.79KB	Share
LDX Change in substantial holding
19/09/24		133.39KB	Share
LDX Change in substantial holder
16/09/24		162.94KB	Share
LDX Change in substantial holding
16/09/24		126.59KB	Share
LDX Lumos Appoints Thermo Fisher Scientific as US Distributor
16/09/24	PRICE SENSITIVE	171.99KB	Share
LDX Change in substantial holding from RYD
13/09/24		146.68KB	Share
LDX Application for quotation of securities - LDX
12/09/24		17.31KB	Share
LDX Letter to Ineligible Shareholders
11/09/24		130.82KB	Share
LDX Letter to Eligible Shareholders
11/09/24		18.22MB	Share
LDX Retail Entitlement Offer Booklet
11/09/24	PRICE SENSITIVE	17.57MB	Share

REFRESH

1 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.5¢		Change 0.025(17.9%)		Mkt cap ! $127.9M

Open	High	Low	Value	Volume
14.5¢	17.0¢	14.5¢	$1.678M	10.51M

Buyers (Bids)

No.	Vol.	Price($)
1	10000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	467233	11

View Market Depth

No.	Vol.	Price($)
1	10000	0.165
9	353829	0.160
6	264595	0.155
8	364479	0.150
5	169487	0.145

Price($)	Vol.	No.
0.170	439233	9
0.175	316858	6
0.180	351401	5
0.185	196410	5
0.190	319572	5

Last trade - 16.14pm 12/09/2025 (20 minute delay)


Last 16.5¢		Change 0.025 ( 20.0 %)
Open	High	Low	Volume
14.5¢	17.0¢	14.5¢	5921570
Last updated 15.59pm 12/09/2025 ?

LDX (ASX) Chart

LUMOS DIAGNOSTICS HOLDINGS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available